• 1. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 2. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 3. Excess electrons in lithium–ethylamine solutions—density, electrical conductivity and EPR studies
  Phys. Chem. Chem. Phys., 1999,1, 3561-3565
• 4. Distinct correlation between (CN2)x units and pores: a low-cost method for predesigned wide range control of micropore size of porous carbon?
  Xiaotong Feng,Lei Bian,Jie Ma,Lei Zhou,Xiayan Wang,Guangsheng Guo,Qiaosheng Pu Chem. Commun., 2019,55, 3963-3966
• 5. Emulsion soft templating of carbide-derived carbon nanospheres with controllable porosity for capacitive electrochemical energy storage?
  M. Zeiger,N. J?ckel,P. Strubel,L. Borchardt,R. Reinhold,W. Nickel,J. Eckert,V. Presser,S. Kaskel J. Mater. Chem. A, 2015,3, 17983-17990

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Phenylmethylamines

Comprehensive Overview of N-(3,5-Difluorobenzyl)-N-methylamine (CAS No. 90390-28-6)

N-(3,5-Difluorobenzyl)-N-methylamine (CAS No. 90390-28-6) is a specialized organic compound widely utilized in pharmaceutical research, agrochemical development, and material science. Its unique structural features, including the difluorobenzyl moiety and methylamine group, make it a valuable intermediate for synthesizing bioactive molecules. This compound has garnered significant attention due to its potential applications in drug discovery, particularly in targeting central nervous system (CNS) disorders and enzyme inhibition.

In recent years, the demand for fluorinated aromatic amines like N-(3,5-Difluorobenzyl)-N-methylamine has surged, driven by the growing interest in precision medicine and sustainable chemistry. Researchers are actively exploring its role in designing next-generation therapeutics, especially for conditions such as neurodegenerative diseases and metabolic syndromes. The compound's lipophilicity and electron-withdrawing properties contribute to its enhanced bioavailability, a critical factor in modern drug formulation.

From a synthetic perspective, CAS No. 90390-28-6 is often employed in cross-coupling reactions and reductive amination processes. Its difluorobenzyl scaffold is particularly advantageous for introducing fluorine atoms into target molecules, a strategy increasingly adopted to improve drug stability and receptor binding affinity. Industry professionals frequently search for high-purity N-(3,5-Difluorobenzyl)-N-methylamine suppliers, reflecting its importance in GMP-compliant manufacturing.

Environmental and regulatory considerations also play a pivotal role in the compound's applications. With the rise of green chemistry initiatives, researchers are optimizing synthetic routes for N-(3,5-Difluorobenzyl)-N-methylamine to minimize waste and energy consumption. Questions like "How to scale up N-(3,5-Difluorobenzyl)-N-methylamine synthesis?" or "What are the alternatives to traditional purification methods?" are frequently discussed in academic forums, highlighting the compound's relevance in process chemistry.

Analytical characterization of CAS No. 90390-28-6 typically involves advanced techniques such as HPLC-MS and NMR spectroscopy, ensuring compliance with pharmaceutical-grade standards. The compound's spectral data and chromatographic profiles are well-documented, aiding in quality control for industrial applications. Additionally, its stability under various storage conditions is a key consideration for logistics and supply chain management.

In summary, N-(3,5-Difluorobenzyl)-N-methylamine represents a critical building block in contemporary chemical research. Its versatility in medicinal chemistry, combined with its alignment with sustainable practices, positions it as a compound of enduring significance. As the scientific community continues to explore fluorine-containing compounds, this molecule is poised to remain at the forefront of innovation in life sciences and industrial chemistry.

• 436086-79-2(Benzenemethanamine,3-fluoro-N-(phenylmethyl)-)
• 55096-88-3(benzyl(4-fluorophenyl)methylamine)
• 162401-03-8(ethyl[(4-fluorophenyl)methyl]amine)
• 134227-41-1(Bis(4-fluorobenzyl)amine)
• 748124-46-1(3,4-Difluoro-N-methyl-benzylamine)
• 405-66-3(4-Fluoro-N-methylbenzylamine)
• 90389-85-8(N-Ethyl-3-fluorobenzylamine)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)